Nasus Pharma CEO and Director Brendan O’Grady files initial beneficial ownership statement

• Nasus Pharma filed an SEC Form 3 for Brendan P. O’Grady, naming him chief executive officer, director.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nasus Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035646), on July 31, 2026, and is solely responsible for the information contained therein.